CALL TODAY 888-882-8602

CAN YOUR CONTINUOUS
GLUCOSE MONITOR (CGM)
HELP YOU DO THIS?

ACT* AHEAD: The only CGM that predicts when you are likely to go low 10-60 minutes before it happens.

STAY AHEAD: Get motivational and helpful insights to help you better understand the hidden reason you go high and low.

Get Started


The Only
Smart** CGM

Compare GuardianTM Connect CGM System
to the Abbott Freestyle Libre System

Medtronic



Medtronic

GuardianTM Connect
CGM System*

Abbott



Abbott

Abbott Freestyle
Libre System
Predictive High Glucose Alerts
 Yes SystemScan
Required for Alert
Low Glucose Detection Alert
 Yes No
Sensor Glucose Alerts
 Yes No
Sugar.IQTM Intelligent Assistant App
Diabetes assistant for data-backed insights
 Yes
 No
Care Partner Monitoring
 Yes No
StartRightSM Program
Personalized Onboarding & Support		 Yes No
FDA Approved Sensor Life
 Up to 7 days
 10 days
Transmitter Life
 2 hours
 12 hours
Transmitter Warranty
 1 year
 10 days
No Dedicated Monitor
Required at Purchase

 Yes

 No

Get More
Than Numbers,
Get Answers

Diabetes management with insulin injections can be better with the right glucose monitoring system. GuardianTM Connect Smart CGM gives you continuous coverage and predictive alerts that no other glucose monitor can. And with the exclusive Sugar.IQTM assistant, you can stay ahead with personal diabetes insights.

GET STARTED TODAY

888-882-8602

 
 
“Getting an alert before I go low helps me to not experience that nervous/weak feeling of already being low. It's like nothing I’ve experienced from other CGM systems.”***

– Brett, Living with Type 1 Diabetes

Take The Next Step
Towards Smart CGM

Order Today 888-882-8602

To get updates and to have a diabetes therapy consultant contact you,
fill out the form below.

Are you an existing Medtronic customer?

Select one or more of the below:

AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

You authorize Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes or its subsidiaries, contractors or representatives to use your personal information, including but not limited to your contact information and health information, for marketing purposes and to share that information with Medtronic representatives and contractors. Information you may receive includes, but is not limited to: (a) Medtronic Diabetes products, therapies or services; (b) marketing and promotional offers; (c) inquiries about your experience with Medtronic Diabetes products, therapies and services; and/or (d) suggestions for how Medtronic Diabetes can enhance its customer support.

This authorization will expire three (3) years from the later of the date you submit this authorization online; or (ii) the last date products or services were received from Medtronic, but may expire sooner if you revoke it by following the instructions below.

You have the right to revoke this authorization at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating my communication preferences at www.diabetes.shop/myhome. A revocation will not affect actions Medtronic Diabetes has already taken based on this authorization. Information disclosed pursuant to this authorization may be re-disclosed by the recipient of the information and may no longer be protected by the federal privacy standards.

You have the right to refuse to sign this authorization. Refusal to sign will not affect your treatment or health insurance eligibility or benefits.

Questions? Contact our Customer Service Center at 800-646-4633, or by email at takecontrol@medtronic.com.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

 
ORDER NOW User Guide Getting Started Guide FAQs Sugar.IQTM
 

*The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.

**Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQTM insights that can inform users of clinically relevant glucose patterns.

***Brett was compensated for spending the day with us and allowing us to photograph him and his children, he is also a family member of a Medtronic employee. Thoughts and experiences shared are his own.

By submitting this form, you are granting Medtronic MiniMed, Inc. ("Medtronic") permission to add your contact information to its database for sending you additional information and communications related to Medtronic products and therapies. You may revoke this permission at any time by e-mailing takecontrol@medtronic.com or by sending a request in writing to: Medtronic MiniMed, Inc. c/o Customer Support, 18000 Devonshire Street, Northridge, CA 91325-1219

Important Safety Information
The GuardianTM Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings in place for accurate operation. A non-functioning mobile device or incorrect settings may prevent the app from issuing alerts. Missing alerts may result in undetected low and high glucose levels. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and www.medtronicdiabetes.com/importantsafetyinformation. .

© Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of MedtronicTM. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

Important Safety Information Terms of Use Notice of Privacy Practices Website Privacy Policy Contact Us